Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7226
CALL
Allegion
ALLE
$13.6B
| $902K | ﹤0.01% |
6,900
-74,000
| -91% | -$10.5M |
|
7227
CALL
Vanguard Consumer Discretionary ETF
VCR
$6B
| $901K | ﹤0.01% |
2,400
-1,900
| -44% | -$686K |
|
|
AMPS
7228
DELISTED
Altus Power
AMPS
| $901K | ﹤0.01% |
+221,285
| New | +$810K |
|
|
GMOI
7229
GMO International Value ETF
GMOI
$664M
| $900K | ﹤0.01% |
+37,916
| New | +$923K |
|
|
GMS
7230
PUT
DELISTED
GMS Inc
GMS
| $899K | ﹤0.01% |
10,600
+4,100
| +63% | +$385K |
|
7231
Forum Energy Technologies
FET
$971M
| $899K | ﹤0.01% |
58,038
+27,274
| +89% | +$411K |
|
7232
Mesa Laboratories
MLAB
$602M
| $899K | ﹤0.01% |
6,817
-3,898
| -36% | -$479K |
|
|
TRST
7233
Trustco Bank Corp NY
TRST
$967M
| $899K | ﹤0.01% |
26,981
+5,495
| +26% | +$191K |
|
7234
CALL
Vanguard Morningstar Mid-Cap ETF
VO
$110B
| $898K | ﹤0.01% |
13,600
+800
| +6% | +$54.3K |
|
7235
PUT
Roundhill S&P 500 0DTE Covered Call Strategy ETF
XDTE
$341M
| $898K | ﹤0.01% |
+17,900
| New | +$940K |
|
7236
Invesco Golden Dragon China ETF
PGJ
$93.3M
| $897K | ﹤0.01% |
+34,277
| New | +$928K |
|
7237
Innovator US Equity Ultra Buffer ETF February
UFEB
$231M
| $896K | ﹤0.01% |
26,938
+7,853
| +41% | +$259K |
|
7238
Rogers Corp
ROG
$2.61B
| $896K | ﹤0.01% |
8,817
+8,524
| +2,909% | +$888K |
|
7239
Xperi
XPER
$317M
| $896K | ﹤0.01% |
87,200
+23,981
| +38% | +$224K |
|
7240
Pacira BioSciences
PCRX
$926M
| $895K | ﹤0.01% |
47,487
-399,046
| -89% | -$7.01M |
|
7241
CALL
Geron
GERN
$983M
| $895K | ﹤0.01% |
252,700
+41,600
| +20% | +$166K |
|
7242
Artisan Partners
APAM
$2.94B
| $894K | ﹤0.01% |
+20,773
| New | +$949K |
|
7243
PUT
WEX
WEX
$6.53B
| $894K | ﹤0.01% |
5,100
+2,700
| +113% | +$506K |
|
7244
CALL
Universal Insurance Holdings
UVE
$1.19B
| $893K | ﹤0.01% |
42,400
+29,400
| +226% | +$615K |
|
7245
PUT
ChargePoint
CHPT
$144M
| $892K | ﹤0.01% |
41,680
-2,410
| -5% | -$59.6K |
|
7246
Veeco
VECO
$3.33B
| $892K | ﹤0.01% |
33,279
+24,832
| +294% | +$721K |
|
7247
CALL
Subversive Congressional Democrats Trading ETF
NANC
$288M
| $891K | ﹤0.01% |
23,100
-217,700
| -90% | -$8.48M |
|
7248
PUT
Frontdoor
FTDR
$5.71B
| $891K | ﹤0.01% |
16,300
-3,800
| -19% | -$206K |
|
7249
CALL
The Ensign Group
ENSG
$10.6B
| $890K | ﹤0.01% |
6,700
+300
| +5% | +$43.6K |
|
7250
Direxion Daily Gold Miners Index Bear 2X ETF
DUST
$78.6M
| $890K | ﹤0.01% |
+1,294
| New | +$737K |
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.